Crunch Time For Aerie At EMA
An EU Marketing Recommendation Could Be In Store For New Glaucoma Treatment
Aerie is already exploring its pricing strategy for Roclanda as the European Medicines Agency this week decides whether the intraocular pressure treatment should be approved in Europe.
You may also be interested in...
The European Medicines Agency this week recommended that five new products be granted EU marketing approval.
Pfizer has been unsuccessful in its appeal against the health technology assessment body’s rejection of the rare heart disease drug, Vyndaqel. Meanwhile, Dr Falk Pharma has received the all-clear to make Jorveza (budesonide) available on the National Health Service for eosinophilic esophagitis.
A study examining 27 drug marketing applications that contained real world data and an idea on how to make it easier for companies to understand which RWD to use were discussed this week at the RAPS EURO Convergence 2021 conference.